Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC introducing DHA supplement line in early 1998 under agreement with Monsanto.

This article was originally published in The Tan Sheet

Executive Summary

GENERAL NUTRITION INTRODUCING DHA DIETARY SUPPLEMENT in early 1998 under an exclusive agreement with Monsanto. GNC is using Monsanto's SeaGold oil with docosahexaenoic acid (DHA), derived from golden marine microalgae, in a series of DHA products that will begin with a dietary supplement in the softgel form and expand to include nutraceuticals and functional foods targeted to specific groups such as the elderly, teens and pregnant and lactating women.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087721

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel